Pricing
Login
Home
Charts
Search
Watchlist
Products

Senores Pharmaceuticals Ltd

SENORES
₹1,090.80-1.99%20 Nov 2026
Reports
Pharma Formulations

Senores Pharmaceuticals Ltd

SENORES
₹1,090.80
-1.99%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹5,024Cr
Close
Close Price
₹1,090.80
Industry
Industry
Pharma Formulations
PE
Price To Earnings
35.52
PS
Price To Sales
6.99
Revenue
Revenue
₹719Cr
Rev Gr TTM
Revenue Growth TTM
39.02%
PAT Gr TTM
PAT Growth TTM
60.21%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
7910280101103114138162171175180192
Growth YoY
Revenue Growth YoY%
30.911.571.760.865.953.430.618.9
Expenses
ExpensesCr
648059777795104112121128126135
Operating Profit
Operating ProfitCr
152221232619345050475458
OPM
OPM%
19.321.926.523.124.917.024.830.629.527.129.830.0
Other Income
Other IncomeCr
120251231371839
Interest Expense
Interest ExpenseCr
235565565879
Depreciation
DepreciationCr
34444568891010
PBT
PBTCr
101813162021264145473948
Tax
TaxCr
3333435111111911
PAT
PATCr
71411131618213034373037
Growth YoY
PAT Growth YoY%
131.126.794.1130.4104.4104.143.821.5
NPM
NPM%
9.013.813.613.015.915.715.318.619.620.916.919.0
EPS
EPS₹
4.08.03.43.95.03.84.66.57.38.06.68.8
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
7910280101103114138162171175180192
Growth YoY
Revenue Growth YoY%
30.911.571.760.865.953.430.618.9
Expenses
ExpensesCr
648059777795104112121128126135
Operating Profit
Operating ProfitCr
152221232619345050475458
OPM
OPM%
19.321.926.523.124.917.024.830.629.527.129.830.0
Other Income
Other IncomeCr
120251231371839
Interest Expense
Interest ExpenseCr
235565565879
Depreciation
DepreciationCr
34444568891010
PBT
PBTCr
101813162021264145473948
Tax
TaxCr
3333435111111911
PAT
PATCr
71411131618213034373037
Growth YoY
PAT Growth YoY%
131.126.794.1130.4104.4104.143.821.5
NPM
NPM%
9.013.813.613.015.915.715.318.619.620.916.919.0
EPS
EPS₹
4.08.03.43.95.03.84.66.57.38.06.68.8

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1435215398633719
Growth
Revenue Growth%
149.4507.185.758.939.0
Expenses
ExpensesCr
1223173309464509
Operating Profit
Operating ProfitCr
2134290168209
OPM
OPM%
13.835.919.422.526.629.1
Other Income
Other IncomeCr
043194737
Interest Expense
Interest ExpenseCr
129222530
Depreciation
DepreciationCr
1210173137
PBT
PBTCr
1122571159179
Tax
TaxCr
04-8123842
PAT
PATCr
183358122137
Growth
PAT Growth%
751.0287.978.4108.360.2
NPM
NPM%
7.023.915.314.719.219.1
EPS
EPS₹
1.88.913.716.126.430.7
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1435215398633719
Growth
Revenue Growth%
149.4507.185.758.939.0
Expenses
ExpensesCr
1223173309464509
Operating Profit
Operating ProfitCr
2134290168209
OPM
OPM%
13.835.919.422.526.629.1
Other Income
Other IncomeCr
043194737
Interest Expense
Interest ExpenseCr
129222530
Depreciation
DepreciationCr
1210173137
PBT
PBTCr
1122571159179
Tax
TaxCr
04-8123842
PAT
PATCr
183358122137
Growth
PAT Growth%
751.0287.978.4108.360.2
NPM
NPM%
7.023.915.314.719.219.1
EPS
EPS₹
1.88.913.716.126.430.7
Sales CAGR
1 Year59%
3 Years162%
5 Years-
TTM39%
EBITDA CAGR
1 Year88%
3 Years137%
5 Years-
TTM63%
PAT CAGR
1 Year108%
3 Years143%
5 Years-
TTM60%
Avg. ROCE
1 Year14%
3 Years10%
5 Years9%
TTM15%
CFO / EBITDA
1 Year37%
3 Years-3%
5 Years-7%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
91031464646
Reserves
ReservesCr
2836174740887957
Current Liabilities
Current LiabilitiesCr
1052248241424412
Non Current Liabilities
Non Current LiabilitiesCr
1334143174215237
Total Liabilities
Total LiabilitiesCr
591316221,2271,6041,681
Current Assets
Current AssetsCr
2751251722812766
Non Current Assets
Non Current AssetsCr
3280371504791914
Total Assets
Total AssetsCr
591316221,2271,6041,681
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
91031464646
Reserves
ReservesCr
2836174740887957
Current Liabilities
Current LiabilitiesCr
1052248241424412
Non Current Liabilities
Non Current LiabilitiesCr
1334143174215237
Total Liabilities
Total LiabilitiesCr
591316221,2271,6041,681
Current Assets
Current AssetsCr
2751251722812766
Non Current Assets
Non Current AssetsCr
3280371504791914
Total Assets
Total AssetsCr
591316221,2271,6041,681

Cash Flow

Consolidated
Standalone
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-10-1-26-4662
Investing Cash Flow
Investing Cash FlowCr
-24-48-54-429-121
Financing Cash Flow
Financing Cash FlowCr
364687573-1
Net Cash Flow
Net Cash FlowCr
2-3798-60
Free Cash Flow
Free Cash FlowCr
-21-48-78-203-203
CFO To PAT
CFO To PAT%
-1,054.2-12.8-78.6-78.751.1
CFO To EBITDA
CFO To EBITDA%
-535.2-8.5-61.8-51.236.9
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-10-1-26-4662
Investing Cash Flow
Investing Cash FlowCr
-24-48-54-429-121
Financing Cash Flow
Financing Cash FlowCr
364687573-1
Net Cash Flow
Net Cash FlowCr
2-3798-60
Free Cash Flow
Free Cash FlowCr
-21-48-78-203-203
CFO To PAT
CFO To PAT%
-1,054.2-12.8-78.6-78.751.1
CFO To EBITDA
CFO To EBITDA%
-535.2-8.5-61.8-51.236.9

Ratios

Consolidated
Standalone
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,6383,4905,024
Price To Earnings
Price To Earnings
45.030.335.5
Price To Sales
Price To Sales
6.65.57.0
Price To Book
Price To Book
3.43.75.0
EV To EBITDA
EV To EBITDA
28.621.825.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
43.063.744.044.353.153.1
OPM
OPM%
13.835.919.422.526.629.1
NPM
NPM%
7.023.915.314.719.219.1
ROCE
ROCE%
3.313.57.58.414.414.9
ROE
ROE%
2.718.516.07.413.013.7
ROA
ROA%
1.76.45.34.87.68.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,6383,4905,024
Price To Earnings
Price To Earnings
45.030.335.5
Price To Sales
Price To Sales
6.65.57.0
Price To Book
Price To Book
3.43.75.0
EV To EBITDA
EV To EBITDA
28.621.825.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
43.063.744.044.353.153.1
OPM
OPM%
13.835.919.422.526.629.1
NPM
NPM%
7.023.915.314.719.219.1
ROCE
ROCE%
3.313.57.58.414.414.9
ROE
ROE%
2.718.516.07.413.013.7
ROA
ROA%
1.76.45.34.87.68.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr7,6126,8146,1475,0244,2844,2024,194
Close PriceClose₹269.40640.55377.551,090.804,128.402,540.90418.25
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE42.0919.6235.5244.6737.9152.41
Price To SalesPS836.516.342.696.996.865.504.06
RevenueRevenueCr91,0742,2897196247641,032
Revenue Growth TTMRev Gr TTM%55.0%24.9%10.2%39.0%47.7%14.7%18.2%
PAT Growth TTMPAT Gr TTM%-80.3%44.3%39.0%60.2%95.7%-48.5%40.7%
Market CapitalizationMkt CapCr7,6126,8146,1475,0244,2844,2024,194
Close PriceClose₹269.40640.55377.551,090.804,128.402,540.90418.25
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE42.0919.6235.5244.6737.9152.41
Price To SalesPS836.516.342.696.996.865.504.06
RevenueRevenueCr91,0742,2897196247641,032
Revenue Growth TTMRev Gr TTM%55.0%24.9%10.2%39.0%47.7%14.7%18.2%
PAT Growth TTMPAT Gr TTM%-80.3%44.3%39.0%60.2%95.7%-48.5%40.7%